These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 28883730)

  • 21. Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer.
    Behl A; Chhillar AK
    Recent Pat Anticancer Drug Discov; 2023; 18(3):325-342. PubMed ID: 35702804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer.
    Kumar L; Baldi A; Verma S; Utreja P
    Pharm Nanotechnol; 2018; 6(2):94-110. PubMed ID: 29866028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
    Zhang J; Tang H; Liu Z; Chen B
    Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Review on Targeting Nanoparticles for Breast Cancer.
    Alqaraghuli HGJ; Kashanian S; Rafipour R
    Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted anticancer therapy: overexpressed receptors and nanotechnology.
    Akhtar MJ; Ahamed M; Alhadlaq HA; Alrokayan SA; Kumar S
    Clin Chim Acta; 2014 Sep; 436():78-92. PubMed ID: 24836529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents.
    Prados J; Melguizo C; Perazzoli G; Cabeza L; Carrasco E; Oliver J; Jiménez-Luna C; Leiva MC; Ortiz R; Álvarez PJ; Aranega A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):21-34. PubMed ID: 23676104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
    J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
    Sultana S; Khan MR; Kumar M; Kumar S; Ali M
    J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanomedicine in treatment of breast cancer - A challenge to conventional therapy.
    Afzal M; Ameeduzzafar ; Alharbi KS; Alruwaili NK; Al-Abassi FA; Al-Malki AAL; Kazmi I; Kumar V; Kamal MA; Nadeem MS; Aslam M; Anwar F
    Semin Cancer Biol; 2021 Feb; 69():279-292. PubMed ID: 31870940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bridging cancer biology and the patients' needs with nanotechnology-based approaches.
    Fonseca NA; Gregório AC; Valério-Fernandes A; Simões S; Moreira JN
    Cancer Treat Rev; 2014 Jun; 40(5):626-35. PubMed ID: 24613464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Perspectives on Nanoparticle-based Targeted Drug Delivery Approaches in Breast Cancer Treatment.
    Pandey P; Khan F; Maqsood R; Upadhyay TK
    Endocr Metab Immune Disord Drug Targets; 2023; 23(10):1291-1302. PubMed ID: 36924095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug Combinations in Breast Cancer Therapy.
    Fisusi FA; Akala EO
    Pharm Nanotechnol; 2019; 7(1):3-23. PubMed ID: 30666921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns.
    Singh S; Sharma A; Robertson GP
    Cancer Res; 2012 Nov; 72(22):5663-8. PubMed ID: 23139207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting integrins for cancer management using nanotherapeutic approaches: Recent advances and challenges.
    Ahmad K; Lee EJ; Shaikh S; Kumar A; Rao KM; Park SY; Jin JO; Han SS; Choi I
    Semin Cancer Biol; 2021 Feb; 69():325-336. PubMed ID: 31454671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
    J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.